STOCK TITAN

WEX CEO sells 28,109 shares after option exercise

WEX’s CEO exercised expiring stock options for 28,109 shares and sold the same number under a pre-arranged Rule 10b5-1 trading plan.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

WEX Inc. (WEX) reports that CEO and President Melissa D. Smith exercised stock options for a total of 28,109 shares of Common Stock on September 1, 2026 at exercise prices of $104.95 and $99.69, then sold 28,109 shares in multiple open‑market transactions at weighted‑average prices between about $186 and $191 per share. These option exercises and subsequent sales occurred automatically under a Rule 10b5‑1 trading plan adopted on June 2, 2026. Footnotes also describe a prior 14,809‑share distribution from the Melissa D. Smith 2024 Trust to her direct ownership and list additional indirect holdings through her husband and several irrevocable trusts.

Positive

  • None.

Negative

  • None.
Insider Smith Melissa D
Role CEO and President
Sold 28,109 shs ($5.34M)
Approx. gross sale proceeds $5.34M
Approx. exercise cost $2.92M
Approx. pre-tax spread $2.42M
Type Security Shares Price Value
Exercise Stock Option (right to buy) F1, F10 23,187 $0.00 $0.00
Exercise Stock Option (right to buy) F1, F11 4,922 $0.00 $0.00
Exercise Common Stock F1, F2 23,187 $104.95 $2.43M
Exercise Common Stock F1 4,922 $99.69 $491K
Sale Common Stock F1, F3, F4 180 $186.48 $34K
Sale Common Stock F1, F4, F5 9,245 $189.12 $1.75M
Sale Common Stock F1, F4, F6 7,575 $189.87 $1.44M
Sale Common Stock F1, F4, F7 11,109 $191.11 $2.12M
holding Common Stock -- -- --
holding Common Stock F8 -- -- --
holding Common Stock F8 -- -- --
holding Common Stock F8 -- -- --
holding Common Stock F9 -- -- --
Holdings After Transaction: Stock Option (right to buy) — 0 contracts (Direct); Common Stock — 126,625 shares (Direct); Common Stock — 18,277 shares (Indirect, By husband); Common Stock — 1,693 shares (Indirect, FBC Irrevocable Trust); Common Stock — 1,692 shares (Indirect, BDC Irrevocable Trust); Common Stock — 1,693 shares (Indirect, GMC Irrevocable Trust); Common Stock — 42,274 shares (Indirect, Melissa D. Smith 2025 Trust)
Footnotes (11)
  1. F1. The reported exercise of options and subsequent sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/2/2026. The reporting person exercised two stock option awards that were scheduled to expire on March 20, 2027 and May 10, 2027, respectively. The options would have been forfeited if not exercised prior to their respective expiration dates.
  2. F2. Reflects distribution of 14,809 shares of common stock in accordance with the terms of the trust on August 28, 2026, from the Melissa D. Smith 2024 Trust, which are now directly held by the reporting person.
  3. F3. The price listed is a weighted average price. These shares were sold for between $186.30 and $186.65, inclusive.
  4. F4. Upon request, the reporting person will provide the Securities and Exchange Commission, WEX Inc. or any security holder of WEX Inc. with full information regarding the number of shares sold at each separate purchase price.
  5. F5. The price listed is a weighted average price. These shares were sold for between $188.26 and $189.25, inclusive.
  6. F6. The price listed is a weighted average price. These shares were sold for between $189.50 and $190.19, inclusive.
  7. F7. The price listed is a weighted average price. These shares were sold for between $191.11 and $191.17, inclusive.
  8. F8. This trust was first described in a Form 4 filed by the reporting person on 06/28/2022.
  9. F9. This trust was first described in a Form 4 filed by the reporting person on 02/25/2026.
  10. F10. This stock option vested with respect to one-third of these shares each on 03/20/2018, 03/20/2019, and 03/20/2020.
  11. F11. Half of the performance based non-statutory stock options ("Performance-Based NSOs") reported on the reporting person's Form 4 dated May 12, 2017 (the "Original Form 4"), vested on June 26, 2020 when the Company's closing stock price was at least $149.54 for twenty consecutive trading days. Another quarter of the Performance-Based NSOs vested on December 29, 2020 when the Company's closing stock price was at least $174.45 for twenty consecutive trading days. The last remaining quarter of the Performance-Based NSOs vested on March 8, 2021 when the Company's closing stock price was at least $199.38 for twenty consecutive trading days. Please reference the Original Form 4 for further information regarding the vesting of the Performance-Based NSOs.
Options exercised at $104.95 23,187 shares Stock options for Common Stock exercised on September 1, 2026 at an exercise price of $104.95 per share, expiring March 20, 2027
Options exercised at $99.69 4,922 shares Stock options for Common Stock exercised on September 1, 2026 at an exercise price of $99.69 per share, expiring May 10, 2027
Common Stock sold at ~$186.48 180 shares Open‑market sale on September 1, 2026 at a weighted‑average price of $186.48 per share, within a range of $186.30–$186.65
Common Stock sold at ~$189.12 9,245 shares Open‑market sale on September 1, 2026 at a weighted‑average price of $189.12 per share, within a range of $188.26–$189.25
Common Stock sold at ~$189.87 7,575 shares Open‑market sale on September 1, 2026 at a weighted‑average price of $189.87 per share, within a range of $189.50–$190.19
Common Stock sold at ~$191.11 11,109 shares Open‑market sale on September 1, 2026 at a weighted‑average price of $191.11 per share, within a range of $191.11–$191.17
Trust distribution to direct holdings 14,809 shares Distribution of Common Stock on August 28, 2026 from the Melissa D. Smith 2024 Trust to Melissa D. Smith’s direct ownership
Indirect holdings in 2025 Trust 42,274 shares Indirect ownership of Common Stock through the Melissa D. Smith 2025 Trust as of September 1, 2026
Rule 10b5-1 trading plan regulatory
"occurred automatically pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price listed is a weighted average price. These shares were sold"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Performance-Based NSOs financial
"Half of the performance based non-statutory stock options ("Performance-Based NSOs")"
non-statutory stock options financial
"performance based non-statutory stock options ("Performance-Based NSOs") reported"
Non-statutory stock options are a type of reward that companies give to employees, allowing them to buy company shares at a set price within a certain period. Unlike formal or government-approved plans, these options are more flexible but may have different tax implications. For investors, they can influence a company's stock price and financial health, making them an important factor to consider.

FAQ

What insider transactions did WEX (WEX) CEO Melissa D. Smith report on September 1, 2026?

She exercised stock options for 28,109 shares of Common Stock and on the same date sold 28,109 shares in multiple open‑market transactions, as disclosed in the Form 4.

How many WEX (WEX) shares did Melissa D. Smith sell and at what prices?

She reported selling a total of 28,109 shares of Common Stock in several trades at weighted‑average prices of about $186.48, $189.12, $189.87, and $191.11 per share, with exact ranges detailed in the footnotes.

What stock options did the WEX (WEX) CEO exercise in this Form 4?

She exercised options for 23,187 shares at an exercise price of $104.95 per share that were scheduled to expire on March 20, 2027, and 4,922 shares at $99.69 per share scheduled to expire on May 10, 2027.

Were Melissa D. Smith’s WEX (WEX) trades made under a Rule 10b5-1 plan?

Yes. The filing states the option exercises and subsequent sales occurred automatically pursuant to a Rule 10b5‑1 trading plan adopted by Melissa D. Smith on June 2, 2026.

What indirect WEX (WEX) holdings does Melissa D. Smith report?

Reported indirect positions include 18,277 shares held by her husband and shares held in several irrevocable trusts, including 1,693, 1,692, and 1,693 shares in three 2022 irrevocable trusts and 42,274 shares in the Melissa D. Smith 2025 Trust.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Smith Melissa D

(Last)(First)(Middle)
C/O WEX INC.
1 HANCOCK STREET

(Street)
PORTLAND MAINE 04101

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
WEX Inc. [ WEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CEO and President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/01/2026M(1)23,187A$104.95149,812(2)D
Common Stock09/01/2026M(1)4,922A$99.69154,734D
Common Stock09/01/2026S(1)180D$186.48(3)(4)154,554D
Common Stock09/01/2026S(1)9,245D$189.12(4)(5)145,309D
Common Stock09/01/2026S(1)7,575D$189.87(4)(6)137,734D
Common Stock09/01/2026S(1)11,109D$191.11(4)(7)126,625D
Common Stock18,277IBy husband
Common Stock1,693IFBC Irrevocable Trust(8)
Common Stock1,692IBDC Irrevocable Trust(8)
Common Stock1,693IGMC Irrevocable Trust(8)
Common Stock42,274IMelissa D. Smith 2025 Trust(9)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$104.9509/01/2026M(1)23,187 (10)03/20/2027Common Stock23,187$00D
Stock Option (right to buy)$99.6909/01/2026M(1)4,922 (11)05/10/2027Common Stock4,922$00D
Explanation of Responses:
1. The reported exercise of options and subsequent sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/2/2026. The reporting person exercised two stock option awards that were scheduled to expire on March 20, 2027 and May 10, 2027, respectively. The options would have been forfeited if not exercised prior to their respective expiration dates.
2. Reflects distribution of 14,809 shares of common stock in accordance with the terms of the trust on August 28, 2026, from the Melissa D. Smith 2024 Trust, which are now directly held by the reporting person.
3. The price listed is a weighted average price. These shares were sold for between $186.30 and $186.65, inclusive.
4. Upon request, the reporting person will provide the Securities and Exchange Commission, WEX Inc. or any security holder of WEX Inc. with full information regarding the number of shares sold at each separate purchase price.
5. The price listed is a weighted average price. These shares were sold for between $188.26 and $189.25, inclusive.
6. The price listed is a weighted average price. These shares were sold for between $189.50 and $190.19, inclusive.
7. The price listed is a weighted average price. These shares were sold for between $191.11 and $191.17, inclusive.
8. This trust was first described in a Form 4 filed by the reporting person on 06/28/2022.
9. This trust was first described in a Form 4 filed by the reporting person on 02/25/2026.
10. This stock option vested with respect to one-third of these shares each on 03/20/2018, 03/20/2019, and 03/20/2020.
11. Half of the performance based non-statutory stock options ("Performance-Based NSOs") reported on the reporting person's Form 4 dated May 12, 2017 (the "Original Form 4"), vested on June 26, 2020 when the Company's closing stock price was at least $149.54 for twenty consecutive trading days. Another quarter of the Performance-Based NSOs vested on December 29, 2020 when the Company's closing stock price was at least $174.45 for twenty consecutive trading days. The last remaining quarter of the Performance-Based NSOs vested on March 8, 2021 when the Company's closing stock price was at least $199.38 for twenty consecutive trading days. Please reference the Original Form 4 for further information regarding the vesting of the Performance-Based NSOs.
Remarks:
/s/ Matthew Finkelstein, as attorney in-fact for Melissa D. Smith09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading